Retension Pharmaceuticals, Inc.

Retension Pharmaceuticals, Inc. announced the appointment of Robert Wong as its new Vice President and Chief Accounting Officer, effective November 2, 2026. Wong, aged 60, has extensive experience in accounting and finance, previously holding senior roles at The Save Mart Companies, Cytokinetics, and Genentech. His compensation package includes an annual base salary of $360,000, eligibility for a discretionary bonus, a $20,000 sign-on bonus, and a stock option award for 25,000 shares.